{
  "trial_id": "NCT00187083",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "treated on frontline protocols at St. Jude",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "isolated bone marrow relapse",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "during or after treatment with multi-agent chemotherapy (TOTAL XI, XII, XIIIA, XIIIB)",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "isolated extramedullary relapse after treatment on TOTXII",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients with recurrent T-Cell non-Hodgkin's lymphoma who relapse in the bone marrow",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "with >25% blasts",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "First relapse after receiving primary therapy or during primary therapy",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Life expectance of at least 8 weeks",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Life expectancy < 8 weeks",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient A is a 30-year-old male with TB, admitted to the hospital after 10 days of cough and fever. He has not any positive history of TB vaccination.",
  "_meta": {
    "topic_id": "46",
    "trial_id": "NCT00187083",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}